Celleration, Inc.

16 articles about Celleration, Inc.

• Celleration, Inc. Release: MIST Therapy Demonstrates Better Healing And Reduced Recidivism In Split Thickness Donor Site Randomized Controlled Trial

  3/26/2015

• Alliqua Biomedical Snaps Up Celleration, Inc. for $30.4 Million

  2/3/2015

• Celleration, Inc. Announces Statistically Significant Better Healing With MIST® Therapy In The IN-BALANCE VLU Randomized Control Trial

  1/27/2015

• Celleration, Inc. Announces Next Generation UltraMIST™ System Receives FDA Clearance

  8/20/2014

• Celleration, Inc. Reaches Key Milestone of 1 Million MIST&#0174 Therapy Treatments

  3/13/2013

• Celleration, Inc. Closing in on $7 Million Round of Funding

  1/15/2013

• Celleration, Inc. Announces First Patient Enrollment in In-Balance VLU Randomized Control Trial

  5/15/2012

• Celleration, Inc. Announces Award-Winning Clinical Results to Reduce Unfavorable Deep Tissue Injury Outcomes

  3/3/2011

• Celleration, Inc. Announces Close of $8 Million Series E Financing

  1/12/2011

• Celleration, Inc. to Present at Piper Jaffray 20th Annual Health Care Conference

  12/1/2008

• Study Shows Celleration, Inc.'s MIST Therapy(R) Expedites Wound Healing

  10/28/2008

• Celleration, Inc. Completes $30 Million Financing

  8/7/2008

• Celleration, Inc. Announces a New ECPN Journal Publication Series 'MIST Therapy(R) System - Thoughts on Therapy'

  3/13/2007

• Celleration, Inc. Announces The Publication Of A Clinical Study: Evaluation Of The Effectiveness Of MIST Ultrasound Therapy For The Healing Of Chronic Wounds

  10/23/2006

• Celleration, Inc. Receives 2005 Tekne Award For Emerging Biotechnology Company; Tekne Awards Honor Key Leaders And Innovators In Minnesota Technology Industries

  11/17/2005

• Celleration, Inc. Receives $20.6 Million In Series C Funding

  11/1/2005